Avandaryl Overdose

As with any medication, it is possible to overdose on Avandaryl. Some common symptoms of an Avandaryl overdose can include sweating, shakiness, and blurry vision. If the overdose was recent, some treatment options can include having the stomach pumped or taking a sugar solution to increase blood sugar.

 

Avandaryl Overdose: An Overview

Avandaryl® (rosiglitazone and glimepiride) is a prescription medication that has been licensed to treat type 2 diabetes. As with all medicines, it is possible to take too much Avandaryl. The effects of an Avandaryl overdose will vary depending on a number of factors, including how much Avandaryl was taken and whether it was taken with any other medicines, alcohol, and/or drugs.
 
If you happen to overdose on Avandaryl, seek medical attention immediately.
 

Symptoms of an Avandaryl Overdose

An Avandaryl overdose can cause low blood sugar (hypoglycemia). Possible symptoms of low blood sugar include:
 
  • Sweating
  • Shakiness
  • Extreme hunger
  • Dizziness
  • Cold sweats
  • Blurry vision.
     
More severe symptoms of low blood sugar include:
 
  • Changes in behavior, such as irritability
  • Loss of coordination
  • Difficulty speaking
  • Confusion
  • Seizures
  • Loss of consciousness
  • Coma
  • Loss of life.
     

Treatment for an Avandaryl Overdose

The treatment for an Avandaryl overdose varies.
 If the Avandaryl overdose was recent, the healthcare provider may use certain medicines or place a tube into the stomach to "pump the stomach." Treatment may also involve supportive care. This type of care consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options for an Avandaryl overdose may include:
 
  • Fluids through an intravenous line (IV)
  • A sugar (glucose) solution to increase blood sugar
  • Other treatments based on the complications that occur.
     
It is important that you seek medical attention immediately if you believe that you may have overdosed on Avandaryl.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;